Syntellis Performance Solutions, a provider of enterprise performance management software, data and intelligence services, has purchased Stratasan, a provider of advanced healthcare market intelligence and data analytics. Syntellis is backed by Thoma Bravo and Madison Dearborn Partners.

As a result of the deal, Syntellis expands its portfolio of intelligent planning and performance services. The resulting combined firm will deliver intelligence and insights to healthcare providers.

“Now more than ever, healthcare organizations need data and intelligence solutions that help them grow profitably and improve outcomes in the face of extraordinary changes and challenges,” said Flint Brenton, CEO of Syntellis. “With the powerful combination of Syntellis’ leading software, data and intelligence solutions and Stratasan’s advanced analytics and market intelligence, we’ll connect operational, financial and strategic data to empower healthcare leaders to improve their performance, deliver exceptional outcomes and maximize their impact in the communities they serve.”   

Ernst & Young Global Limited acted as financial advisor and Kirkland & Ellis LLP served as legal advisor to Syntellis. Canaccord Genuity, LLC acted as financial advisor and McDermott Will & Emery LLP served as legal advisor to Stratasan.